Literature DB >> 18210920

Percutaneous endoscopic gastrostomy in hospitalized incompetent geriatric patients: poorly informed, constrained and paradoxical decisions.

Ilana Golan1, Moshe Ligumsky, Mayer Brezis.   

Abstract

BACKGROUND: The frequency of performing percutaneous endoscopic gastrostomy in demented older people has increased in recent years. Several reports indicate flaws in the criteria for performing PEG and in the decision-making process, raising concerns about the adequacy of the consent.
OBJECTIVES: To assess the knowledge and attitudes of referring doctors and gastroenterologists, and to evaluate attitudes and feelings of family members concerning PEG insertion.
METHODS: We conducted a survey of 72 doctors who referred 126 demented patients for PEG, as well as 126 family members and 34 gastroenterologists. Closed-ended questionnaires were designed for each study group, completed by the participants, and computer analyzed.
RESULTS: Approximately 50% of family members expressed dissatisfaction with the decision-making process. Referring physicians reported that PEG insertion was often dictated by the need to transfer patients to a nursing home, with 50% admitting institutional pressure. Most of the referring physicians believed that PEG improved quality of life and increased longevity, whereas gastroenterologists did not expect an improved quality of life and thought that administrative demands should not intervene in the decision to insert PEG.
CONCLUSIONS: The decision-making process in the patient's families regarding PEG insertion for their demented relative is unsatisfactory, often takes place under pressure, and does not provide sufficient information about the procedure or its complications. Interpersonal communication between the patient's family and the medical team needs to be improved, and institutional demands should not play a major role in the medical decision to insert PEG. Gastroenterologists should take a more active role in the deliberations regarding PEG.

Entities:  

Mesh:

Year:  2007        PMID: 18210920

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  8 in total

1.  [The value of percutaneous endoscopic gastrostomy in ENT tumor patients].

Authors:  K Mantsopoulos; M Koch; J Zenk; H Iro
Journal:  HNO       Date:  2010-04       Impact factor: 1.284

2.  Percutaneous endoscopic gastrostomy (PEG): cui bono?

Authors:  Seamus O'Mahony
Journal:  Frontline Gastroenterol       Date:  2014-10-16

Review 3.  Treatment decision making involving patients with dementia in acute care: A scoping review.

Authors:  Kristen E Pecanac; Mary Wyman; Amy J H Kind; Corrine I Voils
Journal:  Patient Educ Couns       Date:  2018-06-28

Review 4.  Difficulties with percutaneous endoscopic gastrostomy (PEG): a practical guide for the endoscopist.

Authors:  S O'Mahony
Journal:  Ir J Med Sci       Date:  2012-08-21       Impact factor: 1.568

5.  Race, Socioeconomic Status, and Gastrostomy after Spontaneous Intracerebral Hemorrhage.

Authors:  Roxanna M Garcia; Shyam Prabhakaran; Christopher T Richards; Andrew M Naidech; Matthew B Maas
Journal:  J Stroke Cerebrovasc Dis       Date:  2019-12-12       Impact factor: 2.136

6.  Percutaneous endoscopic gastrostomy: Patients' outcomes, adequacy and quality of information given to decision-makers and procedure acceptance.

Authors:  Petros Stathopoulos; George Karamanolis; Ioannis S Papanikolaou; Dimitrios Polymeros; Angelos A Papadopoulos; Konstantinos Triantafyllou
Journal:  Ann Gastroenterol       Date:  2011

Review 7.  How are treatment decisions made about artificial nutrition for individuals at risk of lacking capacity? A systematic literature review.

Authors:  Gemma Clarke; Katy Harrison; Anthony Holland; Isla Kuhn; Stephen Barclay
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

8.  Mapping and understanding the decision-making process for providing nutrition and hydration to people living with dementia: a systematic review.

Authors:  Kanthee Anantapong; Nathan Davies; Justin Chan; Daisy McInnerney; Elizabeth L Sampson
Journal:  BMC Geriatr       Date:  2020-12-02       Impact factor: 4.070

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.